Samay Pharma India Profile
Key Indicators
- Authorised Capital ₹ 1.65 Cr
as on 21-06-2024
- Paid Up Capital ₹ 1.65 Cr
as on 21-06-2024
- Company Age 4 Year, 12 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.96 Cr
as on 21-06-2024
- Revenue %
(FY 2022)
- Profit 3270.61%
(FY 2022)
- Ebitda 7641.26%
(FY 2022)
- Net Worth 290.56%
(FY 2022)
- Total Assets 258.12%
(FY 2022)
About Samay Pharma India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.65 Cr and a paid-up capital of Rs 1.65 Cr.
The company currently has active open charges totaling ₹6.96 Cr.
Priya Aggarwal and Gaurav Jain serve as directors at the Company.
- CIN/LLPIN
U24239DL2020PTC374387
- Company No.
374387
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Dec 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Samay Pharma India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priya Aggarwal  | Director | 10-Dec-2022 | Current |
| Gaurav Jain | Director | 10-Dec-2020 | Current |
Financial Performance of Samay Pharma India.
Samay Pharma India Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 3270.61% increase in profit. The company's net worth Soared by an impressive increase of 290.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Samay Pharma India?
In 2022, Samay Pharma India had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Apr 2023 | ₹9.35 M | Open |
Others Creation Date: 14 Dec 2021 | ₹6.02 Cr | Open |
How Many Employees Work at Samay Pharma India?
Samay Pharma India has a workforce of 1 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Samay Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Samay Pharma India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
